Vimentin, IHC
Strata Select™, EpiSwitch® CiRT for Immunotherapy Management
Nuclear Matrix Proteins 22 (NMP22), Urine
Parathyroid Hormone (PTH), Intact
Prostatic Acid Phosphatase (PAP)
Thyroxine, Free (FT4)
Lymphocytic Choriomeningitis (LCM) Virus Antibody, IgG
Measles, Mumps, Rubella, and Varicella-zoster Viruses (MMRV) Immune Status Profile
Avantect Ovarian Cancer Test
Manganese, Serum
LDS
Sign up
Log in
LDS
/
Medical Tests
/
VENTANA® MET (SP44) RxDx IHC Assay for non-squamous, non-small cell lung cancer (NSQ-NSCLC)
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References
VENTANA® MET (SP44) RxDx IHC Assay for non-squamous, non-small cell lung cancer (NSQ-NSCLC)
Medical Test
Clinical Utility
Access to
VENTANA® MET (SP44) RxDx IHC Assay for non-squamous, non-small cell lung cancer (NSQ-NSCLC)
is restricted.
Sign up now
Loading...